v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash Flows from Operating Activities      
Net loss $ (775) $ (1,063) $ (2,241)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation, amortization and impairment 2,154 1,901 1,636
Stock-based compensation 898 749 467
Amortization of debt discounts and issuance costs 188 159 91
Inventory and purchase commitments write-downs 193 85 132
Loss on disposals of fixed assets 146 162 106
Foreign currency transaction (gains) loss (48) (2) 52
Loss related to SolarCity acquisition     58
Non-cash interest and other operating activities 186 49 135
Operating cash flow related to repayment of discounted convertible notes (188)    
Changes in operating assets and liabilities, net of effect of business combinations:      
Accounts receivable (367) (497) (25)
Inventory (429) (1,023) (179)
Operating lease vehicles (764) (215) (1,523)
Prepaid expenses and other current assets (288) (82) (72)
Other non-current assets 115 (207) (15)
Accounts payable and accrued liabilities 682 1,723 388
Deferred revenue 801 406 469
Customer deposits (58) (96) 170
Resale value guarantee (150) (111) 209
Other long-term liabilities 109 160 81
Net cash provided by (used in) operating activities 2,405 2,098 (61)
Cash Flows from Investing Activities      
Purchases of property and equipment excluding finance leases, net of sales (1,327) (2,101) (3,415)
Purchases of solar energy systems (105) (218) (666)
Purchase of intangible assets (5)    
Receipt of government grants 46    
Business combinations, net of cash acquired (45) (18) (115)
Net cash used in investing activities (1,436) (2,337) (4,196)
Cash Flows from Financing Activities      
Proceeds from issuances of common stock in public offerings, net of underwriting discounts 848   400
Proceeds from issuances of convertible and other debt 10,669 6,176 7,138
Repayments of convertible and other debt (9,161) (5,247) (3,996)
Repayments of borrowings issued to related parties   (100) (165)
Collateralized lease repayments (389) (559) 511
Proceeds from exercises of stock options and other stock issuances 263 296 259
Principal payments on finance leases (321) (181) (103)
Common stock and debt issuance costs (37) (15) (63)
Purchase of convertible note hedges (476)   (204)
Proceeds from settlement of convertible note hedges     287
Proceeds from issuance of warrants 174   53
Payments for settlements of warrants     (230)
Proceeds from investments by noncontrolling interests in subsidiaries 279 437 790
Distributions paid to noncontrolling interests in subsidiaries (311) (227) (262)
Payments for buy-outs of noncontrolling interests in subsidiaries (9) (6)  
Net cash provided by financing activities 1,529 574 4,415
Effect of exchange rate changes on cash and cash equivalents and restricted cash 8 (23) 40
Net increase in cash and cash equivalents and restricted cash 2,506 312 198
Cash and cash equivalents and restricted cash, beginning of period 4,277 3,965 3,767
Cash and cash equivalents and restricted cash, end of period 6,783 4,277 3,965
Supplemental Non-Cash Investing and Financing Activities      
Equity issued in connection with business combination 207    
Acquisitions of property and equipment included in liabilities 562 249 914
Estimated fair value of facilities under build-to-suit leases   94 313
Supplemental Disclosures      
Cash paid during the period for interest, net of amounts capitalized 455 381 183
Cash paid during the period for taxes, net of refunds $ 54 $ 35 $ 66